Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1995 June 1; 181(6): 2017–2027.
PMCID: PMC2192064

T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus


(NZB x NZW) F1 (BWF1) mice develop spontaneous T cell autoimmunity to VH region determinants of syngeneic anti-DNA before the onset of clinical disease. In this study, we characterized the immunogenicity, MHC binding, and lymphokine secretion patterns induced by T cell determinants from the VH region of one such anti-DNA mAb (A6.1) and examined their role in the regulation of autoimmunity. Determinants were identified by proliferation of syngeneic splenic T cells from young, unprimed BWF1 mice in response to overlapping 12-mer peptides representing the entire VH region sequence. Immunization of young BWF1 mice with any of three determinants (A6H 34-45 [p34], A6H 58-69 [p58], and A6H 84-95 [p84]) elicited proliferative responses upon in vitro recall. Upon immunization with the whole A6.1 molecule, however, proliferative responses could be recalled only to the p58 peptide, defining this as immunodominant. The other two peptides (p34 and p84) elicited minimal or no proliferation and could be termed cryptic. Proliferative responses elicited by the cryptic determinants were restricted by a single class II (I-Ed for p34 and I-Au for p84), whereas the immunodominant p58 determinant was restricted by both I-Ed and I-Eu. The cryptic p34 and p84 bound strongly to I-Ed and I-Au, respectively, whereas the immunodominant p58 peptide bound poorly to I- Ed. A6H p84 elicited T cells that secreted lymphokines in a pattern consistent with a Th1-like phenotype, whereas p58 induced a Th2-like cytokine pattern. Immunization with p34 or p84, or adoptive transfer of a p84-reactive T cell line to young BWF1 mice significantly increased IgG anti-DNA levels, accelerated nephritis, and decreased survival. In conclusion, in BWF1 mice, autoreactive T cells recognizing both cryptic and dominant self-determinants on anti-DNA autoantibodies escape deletion or anergy induction. Furthermore, since these cells are spontaneously activated before the onset of clinical disease, they may be involved in the development of the autoimmune process.

Full Text

The Full Text of this article is available as a PDF (1.0M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Steinberg AD, Krieg AM, Gourley MF, Klinman DM. Theoretical and experimental approaches to generalized autoimmunity. Immunol Rev. 1990 Dec;118:129–163. [PubMed]
  • Wofsy D, Seaman WE. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med. 1985 Feb 1;161(2):378–391. [PMC free article] [PubMed]
  • Ando DG, Sercarz EE, Hahn BH. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol. 1987 May 15;138(10):3185–3190. [PubMed]
  • Datta SK, Patel H, Berry D. Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med. 1987 May 1;165(5):1252–1268. [PMC free article] [PubMed]
  • Cawley D, Chiang BL, Naiki M, Ansari AA, Gershwin ME. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice. J Immunol. 1993 Mar 15;150(6):2467–2477. [PubMed]
  • Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. [PMC free article] [PubMed]
  • Ebling FM, Tsao BP, Singh RR, Sercarz E, Hahn BH. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus. Arthritis Rheum. 1993 Mar;36(3):355–364. [PubMed]
  • Germain RN, Ashwell JD, Lechler RI, Margulies DH, Nickerson KM, Suzuki G, Tou JY. "Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A. 1985 May;82(9):2940–2944. [PubMed]
  • Sette A, Southwood S, O'Sullivan D, Gaeta FC, Sidney J, Grey HM. Effect of pH on MHC class II-peptide interactions. J Immunol. 1992 Feb 1;148(3):844–851. [PubMed]
  • Kappler JW, Skidmore B, White J, Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med. 1981 May 1;153(5):1198–1214. [PMC free article] [PubMed]
  • Oi VT, Jones PP, Goding JW, Herzenberg LA, Herzenberg LA. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol. 1978;81:115–120. [PubMed]
  • Bhardwaj V, Kumar V, Geysen HM, Sercarz EE. Subjugation of dominant immunogenic determinants within a chimeric peptide. Eur J Immunol. 1992 Aug;22(8):2009–2016. [PubMed]
  • Ozato K, Mayer N, Sachs DH. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol. 1980 Feb;124(2):533–540. [PubMed]
  • Nygard NR, McCarthy DM, Schiffenbauer J, Schwartz BD. Mixed haplotypes and autoimmunity. Immunol Today. 1993 Feb;14(2):53–56. [PubMed]
  • Müller W, Vandenabeele P. A T cell clone which responds to interleukin 2 but not to interleukin 4. Eur J Immunol. 1987 Apr;17(4):579–580. [PubMed]
  • Mosmann TR, Bond MW, Coffman RL, Ohara J, Paul WE. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5654–5658. [PubMed]
  • Hu-Li J, Ohara J, Watson C, Tsang W, Paul WE. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol. 1989 Feb 1;142(3):800–807. [PubMed]
  • Ohara J, Paul WE. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature. 1985 May 23;315(6017):333–336. [PubMed]
  • Chirmule N, Oyaizu N, Kalyanaraman VS, Pahwa S. Misinterpretation of results of cytokine bioassays. J Immunol Methods. 1991 Mar 1;137(1):141–144. [PubMed]
  • Ohnishi K, Ebling FM, Mitchell B, Singh RR, Hahn BH, Tsao BP. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol. 1994 Jun;6(6):817–830. [PubMed]
  • Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol. 1993;11:729–766. [PubMed]
  • Gotoh Y, Takashima H, Noguchi K, Nishimura H, Tokushima M, Shirai T, Kimoto M. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones. J Immunol. 1993 Jun 1;150(11):4777–4787. [PubMed]
  • Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today. 1993 Jun;14(6):270–274. [PubMed]
  • Bogen B, Weiss S. Processing and presentation of idiotypes to MHC-restricted T cells. Int Rev Immunol. 1993;10(4):337–355. [PubMed]
  • Yurin VL, Rudensky AY, Mazel SM, Blechman JM. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule. Eur J Immunol. 1989 Sep;19(9):1685–1691. [PubMed]
  • Bikoff EK, Eckhardt LA. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells. Eur J Immunol. 1989 Oct;19(10):1903–1909. [PubMed]
  • Rudensky AYu, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA., Jr Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991 Oct 17;353(6345):622–627. [PubMed]
  • Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993 Jul 1;178(1):27–47. [PMC free article] [PubMed]
  • Harris PE, Maffei A, Liu Z, Colovai I, Reed EF, Inghirami G, Suciu-Foca N. Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol. 1993 Dec 1;151(11):5975–5983. [PubMed]
  • Mazel SM, Rudensky AY, Yurin VL. Immunoglobulin-specific T-B cell interaction. III. B cell activation by immunoglobulin-recognizing T cell clones. Eur J Immunol. 1990 Apr;20(4):833–839. [PubMed]
  • Chen JJ, Kaveri SV, Kohler H. Cryptic T cell epitopes in polymorphic immunoglobulin regions: evidence for positive repertoire selection during fetal development. Eur J Immunol. 1992 Dec;22(12):3077–3083. [PubMed]
  • Li WF, Fan MD, Pan CB, Lai MZ. T cell epitope selection: dominance may be determined by both affinity for major histocompatibility complex and stoichiometry of epitope. Eur J Immunol. 1992 Apr;22(4):943–949. [PubMed]
  • Lipham WJ, Redmond TM, Takahashi H, Berzofsky JA, Wiggert B, Chader GJ, Gery I. Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. J Immunol. 1991 Jun 1;146(11):3757–3762. [PubMed]
  • Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994 Jan 1;179(1):305–310. [PMC free article] [PubMed]
  • Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1994 Apr;1(1):73–83. [PubMed]
  • Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1994 Oct;1(7):553–562. [PubMed]
  • Finkelman FD, Holmes J, Katona IM, Urban JF, Jr, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990;8:303–333. [PubMed]
  • Bhardwaj V, Kumar V, Geysen HM, Sercarz EE. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol. 1993 Nov 1;151(9):5000–5010. [PubMed]
  • Puccetti A, Koizumi T, Migliorini P, André-Schwartz J, Barrett KJ, Schwartz RS. An immunoglobulin light chain from a lupus-prone mouse induces autoantibodies in normal mice. J Exp Med. 1990 Jun 1;171(6):1919–1930. [PMC free article] [PubMed]
  • Dang H, Ogawa N, Takei M, Lazaridis K, Talal N. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4. J Immunol. 1993 Dec 15;151(12):7260–7267. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press